Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones
Open accessThe DOI matches its Crossref record.
Abstract
Vaccinia virus-specific cytotoxic T-lymphocyte (CTL) clones were established from a healthy donor, who had been immunized with vaccinia virus vaccine, by stimulation of peripheral blood lymphocytes with UV-inactivated vaccinia virus antigen. The phenotype of all of the clones established was CD3+ CD4+ CD8- Leu11-. We used a panel of allogenic vaccinia virus-infected B-lymphoblastoid cell lines and demonstrated that some of the clones recognized vaccinia virus epitopes presented by human leukocyte antigen (HLA) class II molecules. Monoclonal antibodies specific for either HLA-DP or HLA-DR determinant reduced the cytotoxicity of specific clones. The HLA-restricted cytotoxicity of the clones is vaccinia virus specific, because vaccinia virus-infected but not influenza virus-infected autologous target cells were lysed. Using vaccinia virus deletion mutants, we found that some of the CTL clones recognize an epitope(s) that lies within the HindIII KF regions of the vaccinia virus genome. These results indicate that heterogeneous CD4+ CTL clones specific for vaccinia virus are induced in response to infection and may be important in recovery from and protection against poxvirus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Duration of antiviral immunity after smallpox vaccination
Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M., & Slifka, M. K. (2003) · Nature Medicine · doi:10.1038/nm917 · Cited by 946
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
Miller, J. D., van der Most, R. G., Akondy, R. S., Glidewell, J. T., Albott, S., Masopust, D., Murali-Krishna, K., Mahar, P. L., Edupuganti, S., Lalor, S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.020 · Cited by 601
“Indeed, immunization with either vaccine results in viral replication and long-term protective immunity (Demkowicz and Ennis, 1993; Demkowicz et al., 1996; Littaua et al., 1992; McCarthy et al., 1958; Moss, 1999).”
BackgroundMonkeypox: disease epidemiology, host immunity and clinical interventions
Lum, F.-M., Torres-Ruesta, A., Tay, M. Z., Lin, R. T. P., Lye, D. C., Rénia, L., & Ng, L. F. P. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00775-4 · Cited by 541
Contributions of humoral and cellular immunity to vaccine-induced protection in humans
Amanna, I. J., & Slifka, M. K. (2011) · Virology · doi:10.1016/j.virol.2010.12.016 · Cited by 263
Immunity and immunological memory following smallpox vaccination
Amanna, I. J., Slifka, M. K., & Crotty, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00392.x · Cited by 231
“Vaccinia-specific CD8 T-cell and CD4 T-cell responses in humans were first described 15 years ago (43, 44).”
Background
Metadata
- Authors
- Littaua, R. A., Takeda, A., Cruz, J., & Ennis, F. A.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1992-04
- Volume
- 66
- Issue
- 4
- Pages
- 2274-2280
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2146692566
- Cited by
- 50
- References
- 0
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. https://app.cochat.ai/papers/10.1128/jvi.66.4.2274-2280.1992
- The paper
- Littaua, R. A., Takeda, A., Cruz, J., & Ennis, F. A. (1992). Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. Journal of Virology. https://doi.org/10.1128/jvi.66.4.2274-2280.1992
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.